Today's Rundown - Pfizer, BioNTech gear up to produce 'millions' of COVID-19 vaccine doses by year-end
- Gottlieb, Mostashari propose national COVID-19 surveillance system
- Pfizer finds COVID-19 drug candidate, plots summer testing
- U.S. government issues $1.1B in ventilator contracts to Philips, GM
- Fauci discusses Trump, projected COVID peaks with JAMA
- Gilead supersizes remdesivir trials, changes primary endpoint
- Biopharma roundup: Pfizer, BioNTech look to scale COVID-19 vaccine production; Gilead pivots in remdesivir trials
- Healthcare roundup: AMA releases guidance for volunteer physicians; Walgreens rolls out new telehealth features
- Mylan prepares hydroxychloroquine giveaways after production ramp-up
- 3 lessons from Children's National Hospital on rapidly setting up drive-thru COVID-19 testing
- Mount Sinai creates makeshift assembly line to convert sleep apnea machines into ventilators
- Swelling ranks of COVID-19 vaccines in human testing, Inovio doses its first patients
- Takeda, CSL-led plasma players band together on COVID-19
- Envision Healthcare cuts exec, physician pay as volumes drop amid COVID-19
Featured Story | | | Thursday, April 9, 2020 On the hunt for a COVID-19 vaccine, Pfizer and BioNTech are laying plans for manufacturing their candidates for trials—and, if they're able to start testing by the end of this month, they're planning to gear up "at risk" to produce millions of doses by the end of the year. |
|
|---|
|
Top Stories Wednesday, April 8, 2020 Five healthcare experts, including former government officials Scott Gottlieb and Farzad Mostashari, have proposed a plan to build a national COVID-19 surveillance system. This system to effectively track and trace COVID-19 is a necessary first step for gradually reopening the economy, the healthcare leaders said in a recent paper issued by the Duke-Margolis Center for Health Policy. Thursday, April 9, 2020 Pfizer has found a leading experimental drug candidate against SARS-CoV-2 and is planning to test the drug in the coming months. Thursday, April 9, 2020 The U.S. federal government has tapped Philips to manufacture hospital ventilators for critical COVID-19 care, with the company planning to double its production by May—while the automaker General Motors has been contracted to deliver 30,000 by the end of August. Thursday, April 9, 2020 "The one thing I’ve found to be absolutely clear is, he does listen," NIAID Director Anthony Fauci, M.D., said about President Donald Trump during a chat this week with JAMA's Editor-in-Chief Howard Bauchner. Thursday, April 9, 2020 Gilead has made major mid-study changes to its global remdesivir trials, quadrupling the enrollment target and switching the primary endpoint. The changes come as the world waits for results from the Chinese clinical trials of the advanced COVID-19 antiviral candidate. Thursday, April 9, 2020 Pfizer and BioNTech are hoping to ramp up manufacturing of a possible COVID-19 vaccine to make millions of doses available by year end––but first they have to convince regulators to start human testing this month. Thursday, April 9, 2020 FierceHealthcare's ongoing coverage of how the coronavirus is impacting the healthcare industry. Thursday, April 9, 2020 Mylan is one of a group of drugmakers that have joined the global effort to supply doses of generic hydroxychloroquine, an antimalarial touted as a possible COVID-19 therapy, to ongoing clinical trials. Now, after ramping up production, Mylan is ready to dole out its stockpile faster than expected. Wednesday, April 8, 2020 As many schools around the nation began shuttering for the year due to the pandemic last month, top officials at Children's National Hospital were launching their own response with a COVID-19 drive-thru specimen collection site. Here's how they did it. Wednesday, April 8, 2020 Mount Sinai Health System has developed an assembly area to convert sleep apnea machines into ventilators, but challenges to ensure the devices are safe remain. Thursday, April 9, 2020 With more than 70 vaccine programs targeting the novel coronavirus, we can expect a steady flow of study starts, setbacks and early results. This week, Inovio became the latest to enter human testing, and other teams of researchers are gearing up for their moves into the clinic. Thursday, April 9, 2020 Takeda and CSL Behring have set up an alliance to ramp up the development of such a treatment, joined by other plasma players hailing from the U.K., Switzerland, Germany and France. The group will work on an unbranded treatment made from the plasma of patients who have recovered from COVID-19. Wednesday, April 8, 2020 Envision Healthcare is cutting salaries for its senior leadership by 50% and implementing additional salary cuts and temporary furloughs as it juggles financial woes associated with COVID-19. |
|
